Many pharmaceutical companies already take and keep blood samples from patients in clinical trials, knowing that the DNA therein could expose a genetic basis for side effects. As clinical trials continue growing larger at FDA's request, drugmakers will confront the expanding challenge and cost of storing lots of samples. GenVault aims to convince pharma companies and medical centers that its new automated DNA storage system offers big advantages over freezers conventionally used to store blood.